Management & Directors

Rob Fia

CEO & Chairman of the Board

Mr. Rob Fia was initially involved with Therma Bright Inc. (formerly, The Jenex Corporation) as an investor and now serves as CEO & Chairman of the Board of Directors. Mr. Fia has an extensive contact base in the investment community and the financial sector as well as knowledge of the TSX, TSXV and CSE listing processes and guideline requirements. Mr. Fia’s 18 years’ experience in the investment business has encompassed both equity research and corporate finance advice to early stage, promising companies. Over the past 10 years Mr. Fia has developed a career of working with early stage technology, medical device, mining and oil & gas companies and advising corporate executives on business matters dealing with corporate finance, strategy, expansion, mergers and acquisitions, concept creation, private equity, corporate development, and corporate governance.

Mr. Fia’s transition to CEO of Therma Bright Inc. was only natural given his significant experience working with promising companies and with more than a year of product development at Therma Bright he has transitioned legacy technology that Therma Bright expects to position in the future into substantial revenue. Since taking over as CEO Mr. Fia has retooled the product line and morphed the technology from the legacy cold-sore application (InteceptCS™) from a single activation into a multi-use activation and advanced the predecessor insect bite device into a new thermal therapy insect bite product (TherOZap™). Under Mr. Fia’s leadership the Company is currently developing a thermal therapy pain relief device that will incorporate medical cannabis or CBD from hemp in the form of a creams or gels.

Mr. Fia began his career as a technology analyst with a Toronto based investment bank in 1999 where several of his buy calls were involved in M&A transactions. In 2002 Mr. Fia created his own Limited Market Dealer company involved in financing and advising high growth companies primarily in oil and gas mining, alternative energy and technology. Mr. Fia currently acts as Co-Head Corporate Finance at Kingsdale Capital Markets.Mr. Fia received his B.Comm. (Honours) degree from the I.H. Asper School of Business at the University of Manitoba and holds the Chartered Financial Analyst designation.

Eric Myung, CPA, CA

CFO

Mr. Myung is a senior financial analyst at Marrelli Support Services Inc., providing CFO, accounting, regulatory compliance, and management advisory services to numerous issuers on the TSX, TSX Venture Exchange and other Canadian and US exchanges. Mr. Myung is a CPA, CA and holds a Master of Accounting degree from University of Waterloo. Mr. Myung served as CFO for several TSX Venture Exchange companies. Previously, Mr. Myung worked at a public accounting firm focused on small and medium business for seven years.

DIRECTORS

Tim Peterson, Director

Mr. Peterson has a Bachelor of Arts degree in economics from the University of Western Ontario. He sat on the Board of Directors of Augen Gold, Trelawney Mining, Northern Crown Capital, Inc. (a merchant banking firm), Process Capital, Nordex Explosives and Oxygen and Prescott Paper Products, as well as the Mississauga Hospital Foundation. Mr. Peterson is a former Ontario MPP (Mississauga South). Mr. Peterson is the brother of two prominent Liberal politicians: former Premier of Ontario, David Peterson and former federal cabinet minister, Jim Peterson.

Michael Raimondo, Director

Michael Raimondo, a 30-year veteran in sales and operations in the healthcare industry. Mr. Raimondo is a distinguished executive and strategist known for his extensive commercial leadership experience in the healthcare and business services sectors across the USA. Mr. Raimondo specializes in sales negotiations, which has successfully led to over $500 million in sales contracts.

Mr Raimondo is a retired veteran of the global healthcare industry, having concluded a successful 34 year tenure at Abbott, where he held significant senior leadership positions focusing on commercial strategy and business development.

Following his career at Abbott, Mr. Raimondo transitioned into key advisory and executive roles across various organizations. He currently serves as the Commercial Lead for Delphine Diagnostics in New Jersey (NJ), where he drives market strategy and business growth.

Demonstrating his broad expertise, he also serves as a Managing Partner at The Potentia Group, which specializes in negotiations training, sales leadership development and consulting within the U.S. healthcare market. Michael is an active member of the board for Marketsmith one of the largest woman-owned and operated independent media and marketing agencies in the USA.  Michael has a BS in physics and minor in mathematics from Kutztown University, and has served on the board of the Make A Wish Foundation for the Ohio-Kentucky-Indiana region.